Hexagon Nutrition IPO GMP of Rs 3-4 Signals 7-9% Listing Gain on June 12 — What Allottees and Market Watchers Need to Know
- June 11, 2026
- Posted by: Ankit Jaiswal
- Category: News
Hexagon Nutrition IPO: Listing June 12, 2026 on BSE + NSE. Issue price Rs 45. GMP today (June 11): Rs 3-4, implying listing ~Rs 48-49 (+7-9%). Overall subscription ~16x. QIB 0.41x (low for mainboard). Anchor: Bandhan Small Cap Fund (28.82% of tranche). Pure OFS; company gets no proceeds.
The Hexagon Nutrition IPO is set to make its market debut on Friday, June 12, 2026, listing on both BSE and NSE. Ahead of listing, the GMP as of June 11, 2026, stands at Rs 3-4 per share, suggesting an estimated listing price of Rs 48-49 and a potential 7-9% gain over the issue price of Rs 45. GMP has moderated from its Day 1 peak of approximately Rs 10 per share (implying a 22% premium) to the current Rs 3-4, reflecting the broader market weakness driven by US-Iran tensions and rising crude oil that has dampened IPO listing sentiment this week. The Rs 138.87 crore Hexagon Nutrition IPO, which is a pure OFS (Offer for Sale), closed for subscription on June 9, 2026, receiving approximately 16 times overall subscription.
Click Here – Get Free Research From Univest
Hexagon Nutrition IPO: Key Details
| Parameter | Details |
|---|---|
| IPO Name | Hexagon Nutrition IPO |
| Listing Date | June 12, 2026 (tomorrow) |
| Listing Exchanges | BSE and NSE (mainboard) |
| Issue Price (Upper Band) | Rs 45 per share |
| Price Band | Rs 42-Rs 45 per share |
| GMP Today (June 11) | Rs 3-4 per share |
| Estimated Listing Price | Rs 48-49 (+7-9% over issue price) |
| Peak GMP (Day 1) | Rs 10 per share (~22% implied listing) |
| Overall Subscription | ~16x overall |
| QIB Category | 0.41x (notably low for mainboard) |
| NII (HNI) Category | ~40x |
| Retail Category | ~14-15x |
| Issue Size | Rs 138.87 crore (pure OFS , company receives no proceeds) |
| IPO Structure | 100% OFS (selling shareholders’ exit) |
| Face Value | Rs 1 per share |
| Lot Size | 333 shares |
| Min Investment (Retail) | Rs 14,985 (1 lot = 333 shares) |
| Anchor Investors | Bandhan Small Cap Fund (28.82%), Ampersand Growth, CP Capital |
| BRLMs | Cumulative Capital Pvt Ltd + Catalyst Capital Partners |
| Registrar | KFin Technologies Limited |
| Company Business | Pure-play nutrition: brands Pentasure, Obesigo, Pediagold |
| R&D Facilities | Nasik + Chennai (12 scientists) |
| Employees | 527 (as of March 31, 2026) |
| P/E at Issue Price | 15.35x |
| Market Cap | Rs 553.13 crore |
| Promoter pre-IPO | 89.41% |
| Promoter post-IPO | 64.29% |
Track Hexagon Nutrition IPO and All Upcoming IPO Listings on Univest
Univest covers all mainboard and SME IPO listings with GMP, subscription, and post-listing analysis.
- Live Hexagon Nutrition IPO listing price tracking from June 12
- GMP tracking and subscription data for all active IPOs
- Hold/sell analysis for IPO allottees from Univest research
The Nutrition Business: What Hexagon Nutrition Does
The The company behind this IPO is a pure-play nutrition company with three flagship brands: Pentasure (clinical nutrition), Obesigo (weight management), and Pediagold (paediatric nutrition). The company maintains two in-house R&D facilities in Nasik and Chennai staffed by 12 qualified scientists, supporting a team of 527 employees as of March 31, 2026. The company is research-oriented, with a focus on nutritional formulations for clinical and preventive health segments, which are higher-margin categories with growing institutional demand from hospitals, clinics, and pharmacies. At P/E 15.35x on issue price Rs 45, the Hexagon Nutrition IPO was priced at a modest premium to the sector, with a market cap of Rs 553.13 crore.
QIB Concern and Anchor Investor Comfort
The The QIB category subscription subscription of just 0.41x is an unusual signal for a mainboard issue. However, this was partially offset by strong anchor investor participation: the company raised Rs 41.66 crore from anchor investors on June 4, 2026, led by Bandhan Small Cap Fund (28.82% of the anchor tranche), Ampersand Growth Opportunities Fund (24%), CP Capital (23.16%), Visionary Value Fund (12%), and Innovative Vision Fund (12%). Bandhan Small Cap Fund’s anchor position is a positive signal as domestic small-cap fund managers typically do thorough due diligence before committing anchor capital.
Track Hexagon Nutrition IPO and All IPO Listings on the Univest Screener
Conclusion
The Hexagon Nutrition IPO is set for a cautiously positive listing at Rs 48-49 (+7-9%) based on current GMP of Rs 3-4 on June 12, 2026. The moderated GMP from Day 1’s Rs 10 reflects market conditions. IPO allottees can consider booking listing gains at the opening price. Track live Hexagon Nutrition IPO listing price and all IPO news on Univest. Consult a SEBI-registered advisor before investing.
Download the Univest iOS App or Univest Android App to track Hexagon Nutrition IPO listing price and all IPO listings live on Univest.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the Hexagon Nutrition IPO GMP today?
Ans. The Hexagon Nutrition IPO grey market premium (GMP) today, June 11, 2026, stands at approximately Rs 3-4 per share. Based on the issue price of Rs 45, this implies an estimated listing price of Rs 48-49, representing a potential listing gain of 7-9% for IPO allottees. The GMP has softened significantly from its Day 1 peak of approximately Rs 10 per share (which implied a 22% listing premium). The GMP cooling from Rs 10 to Rs 3-4 reflects the general market weakness from US-Iran tensions and rising crude oil, which has dampened IPO listing sentiment broadly.
What is the Hexagon Nutrition IPO allotment status and listing date?
Ans. The Hexagon Nutrition IPO allotment was finalised on June 10, 2026, by registrar KFin Technologies. Allotted shares were credited to successful applicants’ demat accounts on June 11, 2026 (today). The Hexagon Nutrition IPO is scheduled to list on both BSE and NSE on June 12, 2026, which is tomorrow. Allottees can check their allotment status on the KFin Technologies website using their PAN card or application number.
Why is QIB subscription at 0.41x a concern for Hexagon Nutrition IPO listing?
Ans. The QIB (Qualified Institutional Buyer) subscription of only 0.41x for the Hexagon Nutrition IPO is notably low for a mainboard issue and is a caution signal for listing performance. Typically, strong mainboard IPOs see QIB categories subscribed 5x or more. QIBs include mutual funds, FIIs, and institutional investors who do deep fundamental analysis before bidding. Their absence in this IPO (0.41x) suggests institutional investors found the valuation at Rs 45 (P/E 15.35x) or the business model insufficiently compelling relative to other opportunities. The NII category’s 40x subscription reflects retail HNI speculation rather than fundamental conviction.
Should you hold Hexagon Nutrition shares post listing?
Ans. With the Hexagon Nutrition IPO GMP at Rs 3-4 suggesting a modest 7-9% listing gain, IPO allottees who received shares at Rs 45 have a choice of booking gains at the opening bell or holding for the longer term. The company’s fundamentals show a research-oriented nutrition business with brands like Pentasure, Obesigo, and Pediagold, a market cap of Rs 553 crore, and P/E of 15.35x. The pure OFS structure means the company received no capital from this IPO. Long-term holders should assess revenue growth, new product launches, and distribution expansion before deciding on whether to hold. This is for educational purposes only. Consult a SEBI-registered financial advisor.
